Trial NCT00169221

View at ClinicalTrials.gov 
Org. Study IDs: GORTEC 2004-02

Last trial update was posted on 2011-11-15

MeSH Interventions

Gefitinib

MeSH Conditions

Head and Neck Neoplasms

Other Conditions

Head and Neck Cancer

Stopping Reasons

Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead of 140) despite safety analyses showing no excess of toxicity

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID